Ruxolitinib therapy to Avoid Ventilation and improve outcome for deteriorating COVID-19 patiENts

Project: Research

Project Details

AcronymRAVEN
StatusFinished
Effective start/end date1/06/202015/02/2022

Funding

  • LifeArc: £128,951.00